广州市基准医疗有限责任公司 AnchorDx Medical Co. Ltd
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests 2023-11-13 21:00
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests 2023-11-13 21:00
AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S. 2022-11-23 22:00
AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements 2022-06-15 21:00
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer 2022-03-07 09:00
AnchorDx Achieves Academic Breakthrough with Deep Methylation Representation Learning Research Paper Accepted by 36th AAAI Conference 2021-12-09 22:00
Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy 2021-10-11 21:00
AnchorDx Develops New Liquid Biopsy Diagnostic Model for Early Detection of Breast Cancer 2021-09-13 21:00
AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA 2021-07-21 21:02
2021 ASCO - AnchorDx Unveils Robust Validation Result of Multi-cancer Screening Technology AURORA 2021-06-21 23:19
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test" 2021-04-28 21:00
AACR Annual Meeting 2021: AnchorDx Unveils High-Performance Blood Test for Gastric Cancer Screening 2021-04-19 21:00
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs 2021-02-23 09:02
1